CA3026756C - Method for producing diphenylmethane derivative - Google Patents

Method for producing diphenylmethane derivative Download PDF

Info

Publication number
CA3026756C
CA3026756C CA3026756A CA3026756A CA3026756C CA 3026756 C CA3026756 C CA 3026756C CA 3026756 A CA3026756 A CA 3026756A CA 3026756 A CA3026756 A CA 3026756A CA 3026756 C CA3026756 C CA 3026756C
Authority
CA
Canada
Prior art keywords
compound
formula
mmol
reaction
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3026756A
Other languages
English (en)
French (fr)
Other versions
CA3026756A1 (en
Inventor
Hee-Kyoon Yoon
Se-Hwan Park
Ji-Sung Yoon
Soongyu Choi
Hee Jeong Seo
Eun-Jung Park
Younggyu Kong
Kwang-Seop Song
Min Ju Kim
So Ok PARK
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daewoong Pharmaceutical Co Ltd
GC Biopharma Corp
Original Assignee
Green Cross Corp Korea
Daewoong Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60664449&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA3026756(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Green Cross Corp Korea, Daewoong Pharmaceutical Co Ltd filed Critical Green Cross Corp Korea
Priority to CA3081033A priority Critical patent/CA3081033C/en
Publication of CA3026756A1 publication Critical patent/CA3026756A1/en
Application granted granted Critical
Publication of CA3026756C publication Critical patent/CA3026756C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D9/00Crystallisation
    • B01D9/005Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B51/00Introduction of protecting groups or activating groups, not provided for in the preceding groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA3026756A 2016-06-17 2017-06-15 Method for producing diphenylmethane derivative Active CA3026756C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA3081033A CA3081033C (en) 2016-06-17 2017-06-15 Method for producing diphenylmethane derivative

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2016-0075910 2016-06-17
KR20160075910 2016-06-17
PCT/KR2017/006271 WO2017217792A1 (ko) 2016-06-17 2017-06-15 다이페닐메탄 유도체의 제조방법

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA3081033A Division CA3081033C (en) 2016-06-17 2017-06-15 Method for producing diphenylmethane derivative

Publications (2)

Publication Number Publication Date
CA3026756A1 CA3026756A1 (en) 2017-12-21
CA3026756C true CA3026756C (en) 2021-03-02

Family

ID=60664449

Family Applications (2)

Application Number Title Priority Date Filing Date
CA3026756A Active CA3026756C (en) 2016-06-17 2017-06-15 Method for producing diphenylmethane derivative
CA3081033A Active CA3081033C (en) 2016-06-17 2017-06-15 Method for producing diphenylmethane derivative

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA3081033A Active CA3081033C (en) 2016-06-17 2017-06-15 Method for producing diphenylmethane derivative

Country Status (29)

Country Link
US (2) US10640496B2 (https=)
EP (2) EP3473621B1 (https=)
JP (4) JP6763978B2 (https=)
KR (2) KR102233229B1 (https=)
CN (2) CN113651803B (https=)
AU (1) AU2017285813B2 (https=)
CA (2) CA3026756C (https=)
CL (1) CL2018003645A1 (https=)
CO (1) CO2018014018A2 (https=)
DK (2) DK3663292T3 (https=)
DO (1) DOP2018000287A (https=)
EC (1) ECSP19000185A (https=)
ES (2) ES2898336T3 (https=)
HR (1) HRP20211670T8 (https=)
HU (1) HUE056428T2 (https=)
MA (2) MA44545B2 (https=)
MX (2) MX392177B (https=)
MY (1) MY203941A (https=)
NZ (1) NZ749398A (https=)
PE (2) PE20240590A1 (https=)
PH (1) PH12018550206A1 (https=)
PL (2) PL3663292T3 (https=)
PT (2) PT3663292T (https=)
RS (1) RS62550B1 (https=)
SA (2) SA521422474B1 (https=)
SG (2) SG10201911782RA (https=)
SI (1) SI3663292T1 (https=)
TN (1) TN2018000437A1 (https=)
WO (1) WO2017217792A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011054773A1 (de) 2011-10-25 2013-04-25 Vb Autobatterie Gmbh & Co. Kgaa Anschlusspol für einen Akkumulator, Akkumulatorgehäuse und Maschine zur Herstellung eines Anschlusspols
EP3838894B1 (en) 2018-08-13 2024-03-13 Daewoong Pharmaceutical Co., Ltd. Method for producing intermediate useful for synethesis of sglt inhibitor
CN112341416A (zh) * 2019-08-09 2021-02-09 天津津艺医药科技发展有限责任公司 一种制备苯并含氧脂杂环衍生物的方法
EP4112612B1 (en) 2020-02-27 2025-10-22 Daewoong Pharmaceutical Co., Ltd. Intermediate useful for synthesis of sglt inhibitor and method for preparing sglt inhibitor using same
CN112094253B (zh) * 2020-09-10 2023-01-10 株式会社大熊制药 用于制备sglt抑制剂中间体的合成方法
PE20231373A1 (es) 2020-09-10 2023-09-07 Daewoong Pharmaceutical Co Ltd Metodo de sintesis para la preparacion de un intermedio de inhibidores de sglt
CN113200860B (zh) * 2021-04-29 2024-07-30 爱斯特(成都)生物制药股份有限公司 一种sglt2抑制剂中间体的制备方法
KR20230046784A (ko) * 2021-09-30 2023-04-06 주식회사 대웅제약 이나보글리플로진을 포함하는 약학 조성물
CN113801010A (zh) * 2021-11-18 2021-12-17 山东诚创蓝海医药科技有限公司 一种5-溴-2-氯苯甲酸的制备方法
CN113912487B (zh) * 2021-11-23 2024-05-28 山东研峰新材料科技有限公司 一种2,5-双卤代苯甲酸的合成方法
KR20230110001A (ko) * 2022-01-14 2023-07-21 주식회사 대웅제약 Ssglt 저해제의 합성에 유용한 중간체의 제조 방법
KR20240044194A (ko) 2022-09-28 2024-04-04 주식회사 대웅제약 이나보글리플로진의 신규한 공결정
KR20240044190A (ko) 2022-09-28 2024-04-04 주식회사 대웅제약 이나보글리플로진의 신규한 결정형 및 이의 제조방법
CN119968202A (zh) 2022-09-29 2025-05-09 株式会社大熊制药 用于预防或治疗心血管衰老疾病的包含依那格列净的药物组合物
WO2024076177A1 (ko) 2022-10-05 2024-04-11 주식회사 대웅제약 이나보글리플로진을 포함하는 신장애 및/또는 당뇨병 예방 또는 치료용 약학 조성물
CN120435283A (zh) 2022-12-21 2025-08-05 大熊治疗株式会社 包含依那格列净的滴眼剂形式的药物组合物
KR20240107660A (ko) 2022-12-30 2024-07-09 주식회사 대웅제약 이나보글리플로진 및 메트포르민을 포함하는 약학 조성물
KR102837941B1 (ko) * 2024-11-13 2025-07-25 대웅바이오(주) Inline quenching 공정을 도입한 연속반응 공정을 이용한 이나보글리플로진 합성방법
KR102853437B1 (ko) * 2024-11-13 2025-09-04 대웅바이오(주) 연속반응 공정을 이용한 이나보글리플로진 합성방법
KR102837948B1 (ko) * 2024-11-13 2025-07-25 대웅바이오(주) 분배 투입법을 도입한 연속반응 공정을 이용한 이나보글리플로진 합성방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966907A (en) * 1988-08-12 1990-10-30 Merck & Co., Inc. 6-substituted 5-hydroxy-2,3-dihydrobenzofurans as inhibitors of leukotriene biosynthesis
LT2896397T (lt) * 2003-08-01 2017-11-27 Mitsubishi Tanabe Pharma Corporation Nauji junginiai, turintys inhibitorinį aktyvumą prieš nuo natrio priklausomą gliukozės transporterį
AU2008279424B2 (en) 2007-07-26 2013-06-13 Lexicon Pharmaceuticals, Inc. Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
PE20110208A1 (es) 2008-07-30 2011-03-28 Ferrer Int Compuestos de 1,6-dihidro-2h-3-oxa-6-aza-as-indaceno
US8163704B2 (en) 2009-10-20 2012-04-24 Novartis Ag Glycoside derivatives and uses thereof
WO2012041898A1 (en) * 2010-09-29 2012-04-05 Celon Pharma Sp. Z O.O. Combination of sglt2 inhibitor and a sugar compound for the treatment of diabetes
WO2012165914A2 (en) * 2011-06-01 2012-12-06 Green Cross Corporation Novel diphenylmethane derivatives as sglt2 inhibitors
US9340521B2 (en) 2013-03-18 2016-05-17 Green Cross Corporation Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives
FR3017868A1 (fr) 2014-02-21 2015-08-28 Servier Lab Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
MX2018015647A (es) 2019-04-11
JP2023145481A (ja) 2023-10-11
JP7773506B2 (ja) 2025-11-19
SG11201811154QA (en) 2019-01-30
MA44545A1 (fr) 2019-10-31
KR102233229B1 (ko) 2021-03-29
SG10201911782RA (en) 2020-02-27
RU2021129636A (ru) 2021-11-22
ECSP19000185A (es) 2019-01-31
HUE056428T2 (hu) 2022-02-28
PE20190467A1 (es) 2019-04-04
JP2020117528A (ja) 2020-08-06
HRP20211670T1 (hr) 2022-02-18
RU2019101056A3 (https=) 2020-07-17
CA3081033C (en) 2022-04-12
SA521422474B1 (ar) 2023-11-02
MY203941A (en) 2024-07-25
JP7352509B2 (ja) 2023-09-28
AU2017285813A1 (en) 2019-01-17
EP3473621B1 (en) 2021-08-04
EP3473621A4 (en) 2020-03-11
RU2019101056A (ru) 2020-07-17
MA50774B1 (fr) 2022-02-28
MA44545B2 (fr) 2020-11-30
CN109311861B (zh) 2021-08-24
EP3473621A1 (en) 2019-04-24
SA518400666B1 (ar) 2021-11-30
PH12018550206A1 (en) 2019-09-30
BR112018076243A2 (pt) 2019-03-26
EP3663292A1 (en) 2020-06-10
EP3663292B1 (en) 2021-09-01
DK3473621T3 (da) 2021-09-06
PE20240590A1 (es) 2024-03-21
NZ749398A (en) 2020-01-31
PL3473621T3 (pl) 2022-01-10
MA44545B1 (fr) 2020-05-29
US10889574B2 (en) 2021-01-12
PL3663292T3 (pl) 2022-01-17
CN113651803B (zh) 2022-10-28
ES2891825T3 (es) 2022-01-31
JP2019521985A (ja) 2019-08-08
CO2018014018A2 (es) 2019-03-08
WO2017217792A1 (ko) 2017-12-21
KR20170142904A (ko) 2017-12-28
CA3081033A1 (en) 2017-12-21
DK3663292T3 (da) 2021-10-25
ES2898336T3 (es) 2022-03-07
CN113651803A (zh) 2021-11-16
JP2021152054A (ja) 2021-09-30
CL2018003645A1 (es) 2019-03-22
US20190169174A1 (en) 2019-06-06
MX2021008988A (es) 2022-05-05
SI3663292T1 (sl) 2022-01-31
PT3473621T (pt) 2021-10-04
JP6763978B2 (ja) 2020-09-30
AU2017285813B2 (en) 2020-02-06
MX385640B (es) 2025-03-18
US10640496B2 (en) 2020-05-05
MX392177B (es) 2025-03-19
RS62550B1 (sr) 2021-12-31
US20190382390A1 (en) 2019-12-19
JP7669206B2 (ja) 2025-04-28
PT3663292T (pt) 2021-11-08
MA50774A1 (fr) 2021-03-31
CA3026756A1 (en) 2017-12-21
CN109311861A (zh) 2019-02-05
DOP2018000287A (es) 2019-03-31
KR20210036892A (ko) 2021-04-05
TN2018000437A1 (en) 2020-06-15
HRP20211670T8 (hr) 2022-03-18
KR102379584B1 (ko) 2022-03-29

Similar Documents

Publication Publication Date Title
CA3026756C (en) Method for producing diphenylmethane derivative
EP3133071B1 (en) C-aryl indican derivative, and pharmaceutical composition thereof, preparation method therefor and uses thereof
US20260078109A1 (en) Method for preparing sglt inhibitor
CN102046645A (zh) 螺酮缩醇衍生物的结晶及其制备方法
RU2814846C1 (ru) Способ получения производного дифенилметана
RU2774998C2 (ru) Способ получения производного дифенилметана
RU2797392C2 (ru) Способ получения производного дифенилметана
HK40057423B (en) Method for producing diphenylmethane derivative
HK40057423A (en) Method for producing diphenylmethane derivative
HK40002293A (en) Method for producing diphenylmethane derivative
HK40002293B (zh) 用於制备二苯基甲烷衍生物的方法
BR112018076243B1 (pt) Método para produzir um composto derivado de difenil metano e forma cristalina do composto produzido pelo dito método

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20181206

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 8TH ANNIV.) - STANDARD

Year of fee payment: 8

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241222

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241223